GILD

NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$170.77

+1.04 (+0.61%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 30 83%

Hold 6 17%

Sell 0 0%

Price Target

Analyst Price Target +112.4% upside

Low Target $213.16

Average Target $362.68

High Target $477.67

Current Price $170.77

Current
$170.77

Target
$362.68

$213.16 $362.68 avg $477.67

Scenario Analysis

Bear Case

$213.16

24.8%

Low target

Base Case

$362.68

+112.4%

Avg target

Bull Case

$477.67

+179.7%

High target

Risk/Reward

7.2x

Highly favorable

Price in Context

52-Week High

$176.58

-3.3% from high

52-Week Low

$116.88

+46.1% from low

50-Day SMA

$154.40

+10.6% vs SMA

200-Day SMA

$141.44

+20.7% vs SMA

RSI (14)

66.2

Neutral

Target vs 52W High

$362.68

+105.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-13.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.5%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+112.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	32%	$149.45	-38.8%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-36.1%